Trial Profile
Aldosterone Antagonists [Eplerenone] in Systemic Right Ventricle: a Randomized Clinical Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Right ventricular dysfunction
- Focus Biomarker; Therapeutic Use
- Acronyms EVEDES
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 30 Nov 2011 Actual patient number is 26 according to ClinicalTrials.gov.
- 30 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.